Reslizumab bulk supplier for pharma manufacturers

Reslizumab 10mg/ml Suppliers & Bulk Manufacturers

Available Forms: Injection

Available Strengths: 10mg/ml

Reference Brands: CINQAIR (USA), CINQAERO (EU)

Reslizumab is a Immune Disorder product available as Injection in strengths 10mg/ml. It corresponds to the reference brands CINQAIR (USA), CINQAERO (EU). Verified GMP manufacturers and suppliers on PharmaTradz offer it in bulk for import worldwide, with regulatory documentation and dossier support available on request.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

Reslizumab — third party manufacturing & bulk supply

Reslizumab 10mg/ml is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.

Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.

Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Reslizumab is supplied as Injection — an injectable dosage form, so the indicative MOQ is 50,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Reslizumab listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Reslizumab →

Back to Listing

Frequently Asked Questions

Reslizumab is listed as Injection in 10mg/ml. Further strengths and pack presentations are confirmed with the manufacturer at RFQ stage.

Reslizumab is referenced against CINQAIR (USA), CINQAERO (EU). Reference brands are shown for identification only and remain the property of their respective trademark owners.